Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)
- Conditions
- Pharynx; AnomalyApnea, PostanestheticDesaturation of BloodLarynx DiseaseAnesthesiaApnea
- Interventions
- Device: optiflow
- Registration Number
- NCT03843580
- Lead Sponsor
- University Hospital, Caen
- Brief Summary
Suspension laryngoscopy is realised during apnea. In effect, surgeons are in the mouth of the patient and we can't have access at the aiways.
So investigators like to use a Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) to increase time of apnea and decrease the impact of oxygen desaturation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- suspension laryngoscopy
- THRIVE contraindication:
- epistaxis
- undrained pneumothorax
- Recent gastroesophageal surgery (1months)
- Skull Fractures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description oxygenation optiflow optiflow optiflow oxygenation during apnea
- Primary Outcome Measures
Name Time Method desaturation defined as the number of patient who presented at least one desaturation during suspension laryngoscopy Two hours the number of patient who presented at least one desaturation during suspension laryngoscopy. An oxygen desaturation define like SpO2\<96%
- Secondary Outcome Measures
Name Time Method hypoxemia (decrease the number of Hypoxemia event define like SpO2<90%) 2 hours Decrease the number of Hypoxemia event define like SpO2\<90%
side effect 2 hours decrease the number of side effects
Trial Locations
- Locations (2)
Centre François Baclesse
🇫🇷Caen, France
CaenUH
🇫🇷Caen, Normandie, France